Background: Adrenocortical carcinoma (ACC) is a limited endocrine fatality with a minor diagnosis and rare remedial options. The progressive and predictive meaning of message RNA (mRNA) expression oddity in ACC has been studied extensively in recent years. However, differences in measurement platforms and lab protocols as well as small sample sizes can render gene expression levels incomparable. Methods: An extensive study of GEO datasets was conducted to define potential mRNA biomarkers for ACC. The study compared the mRNA expression profiles of ACC tissues and neighboring noncancerous adrenal tissues in the pair. The study covered a sum of 165 tumors and 36 benign control samples. Hub genes were identified through a protein-protein interaction (PPI) network and Robust Rank Aggregation method. Then the Cancer Genome Atlas (TCGA) and Oncomine database were used to perform the validation of hub genes. 4 ACC tissues and 4 normal tissues were collected and then Polymerase Chain Reaction (PCR), Western-blot and immunofluorescence were conducted to validate the expression of five hub genes. Results: We identified five statistically significant genes (TOP2A, NDC80, CEP55, CDKN3, CDK1) corrected with clinical features. The expression of five hub genes in TCGA and Oncomine database were significantly overexpressed in ACC compared with normal ones. Among all the TCGA ACC cases, the strong expression of TOP2A (logrank p=1.4e-04, HR=4.7), NDC80 (logrank p=8.8e-05, HR=4.9), CEP55 (logrank p=5.2e-07, HR=8.6), CDKN3 (log rank p=2.3e-06, HR=7.6) and CDK1 (logrank p=7e-08, HR=11) were correlated with low comprehensive survival, disease free survival (logrank p < 0.001), pathology stage and pathology T stage (FDR < 0.001). PCR results showed that the transcriptional levels of these five genes were significantly higher in ACC tissues than in normal tissues. The western blotting results also showed that the translational level of TOP2A was significantly higher in tumor tissues than in normal tissues. The results of immunofluorescence showed that TOP2A was abundantly observed in the adrenal cortical cell membrane and nucleus and its expression in ACC tissues was significantly higher than that in normal tissues. Conclusions: The distinguished five genes may be utilized to form a board of progressive and predictive biomarkers for ACC for clinical purpose.
Introduction
Although adrenocortical carcinoma (ACC) is uncommon, it is a lethal malignancy that accounts for 0.7-2.0 out of one million cases annually [1] [2] [3] . Despite of its rarity, it is extremely threatening and the 5-year
Ivyspring
International Publisher survival rate reaches merely 10-20%. Therefore, there is an urgent need for the new therapeutic and diagnostic approaches. It requires the understanding of its molecular basis [4] [5] [6] [7] [8] . The genetic background and gene combination of adrenocortical tumorigenesis are poorly characterized. However, only a small amount of studies have attempted to identify this process from a molecular perspective [9] .
Tumor size is one of the primordial pathological characteristics to indicate cancerous act and positively correlated with malignancy [10, 11] . A full surgical abscission is now the only treatment that is potential to cure the cancerous tumor. Other forms of therapy like chemotherapy or radio have merely a limited influence on the survival of the patient [12] . Consequently, detailed analysis of the relevant pivotal genes is extremely beneficial. The establishment of the cDNA microarray technique provides the possibility to evaluate a huge quantity of genes. This approach compares and analyzes the gene-expression profiles in malignant and benign adrenocortical neoplasms. It also helps with the recognition of tumor suppressor genes and oncogenes related with the occurrence and development of adrenocortical tumors. Results from these studies might make adrenocortical tumorigenesis clear and bring the invention of novel markers for diagnosis, predictions and the identification of new therapeutic treatment.
Consequently, we aimed to carry out a representative and comprehensive study of cancerous and noncancerous adrenocortical tissue samples. Special importance was attached to the assessment of the disparate profiles with affirmative significance for progression and development of cancerous diseases [13] , to evaluate the possibilities of gene combinations in forecasting cancerous tumors [4] . Genome-wide gene expression has been used by several investigators profiling. Some potential diagnostic biomarkers of adrenocortical carcinoma and molecular profiles distinguishing malignant from normal adrenocortical neoplasms have been identified [14] [15] [16] [17] However, these researches obtained the divergent individual candidate genes. It is probably the result of varying approaches to relevant small sample size and data analysis. Besides, as far as we know, no strict analysis of the progressive and prognostic prediction of the prospective biomarkers in adrenocortical carcinoma has been carried out. Thus, the genome-wide expression analysis of normal samples and ACC was identified to identify candidate biomarkers.
In prevailing study, we used Gene Expression Omnibus (GEO) database to download six different microarray datasets and a solid rank aggregation analysis was applied. After that, we used The Cancer Genome Atlas, The Genotype-Tissue Expression (GTEx) and Oncomine database to validate the hub genes. Furthermore, we collected ACC tissues and normal tissues to verify the results of our previous analysis. We aimed to search and confirm diverse hub genes that is effective in the advance and prediction of ACC.
Materials and methods

Data collection
Gene expression profiles were downloaded from Gene Expression Omnibus (GEO) database (http:// www.ncbi.nlm.nih.gov/geo/). Datasets GSE12368, GSE14922, GSE19750, GSE 33371, GSE75415, GSE90713 were used to select disparate expressed genes and establish protein-protein interaction networks. They were also use to conduct robust rank analysis, distinguish hub genes and pathways.
Data processing
Raw microarray data were executed in RMA background correction and log2 transformed then normalized through quantile normalization. The "Affy" R package was applied to sum up the Median-polish probe sets [18] . Finally, sample clustering was used to evaluate the microarray quality following the distance between average linkage and various samples in Pearson's correlation models.
Robust rank aggregation analysis
The extracted mRNAs were classified according to their correlated p values (the significance level was defined as p<0.05) while their fold changes were not reported. All the Robust Rank Aggregation method protocols are accessible at R Archive Network website (http://cran.r-project.org/) and details are obtained from the documentation package (http://cran. rproject.org/web/packages/RobustRankAggreg/Ro bustRankAggreg.pdf). Each element was assigned with a p value in the aggregated list, which indicates its ranking improvement in comparison with a null model, assuming random ordering [19] .
Functional and pathway enrichment analysis
KEGG Orthology Based Annotation System (http://kobas.cbi.pku.edu.cn/index.php), based on multiple databases about pathways, diseases, and gene ontology, was used to execute KEGG pathway enrichment analysis and GO enrichment analysis [20] .
PPI network construction
Search Tool for the Retrieval of Interacting Genes (STRING) Database (http://www.string-db.org/) was used to evaluate protein-protein interaction (PPI) data [21] . In addition, the database was also employed to quantify the interrelationships of analyzed differentially expressed genes (DEGs). Results are visualized in Cytoscape software [22] . Confidence score higher than 0.4 was set as significant. It should be noted that hub genes were those that had a connectivity degree over 20 in the PPI network.
Validation of hub genes expression levels
Gene Expression Profiling Interactive Analysis (http://gepia.cancer-pku.cn) and Oncomine (https:// www.oncomine.org) were used to carry out validation of expression of the candidate hub genes [23, 24] .
Prognostic value of each hub gene in the TCGA dataset
Based on TCGA database, Gene Expression Profiling Interactive Analysis (http://gepia.cancerpku.cn) was used to investigate the relationship between the expression of each hub gene and overall survival (OS) or disease-free survival (DFS) analysis. Log rank test and the Mantel-Cox test were used for hypothesis test. Cohorts thresholds were adjusted and gene-pairs were used. The survival plots also contained the cox proportional hazard ratio and the p = 0.05 significance level.
Progressive value of each hub gene in the TCGA dataset
According to the TCGA database, the Linked Omics database (http://www.linkedomics.org) was used to investigate the relationship between each hub gene expression and ACC pathology stages and pathology T stages [25] .
Human tissues
Four normal samples from young brain-dead men (mean age, 33.1±1.7 years old) undergoing organ donation were obtained as controls and four ACC samples obtained from patients (mean age, 52.7±2.1 years old) undergoing laparoscopic unilateral adrenalectomy. All human samples were obtained after the approval of the Hospital Committee for Investigation in Humans and after receiving written informed consent from all patients or their relatives involved. All tissues were divided into 3 strips and were respectively stored in RNA Sample Protector (Takara Bio. Inc., Otsu, Shiga, Japan) for PCR analysis, 10% neutral buffered formalin for histological examination, liquid nitrogen for Western-Blotting analysis and immunofluorescence. All human study was conducted in accordance with the principles of the Declaration of Helsinki (approval no. 2015029).
Total RNA extraction and real-time RT-PCR
Total RNA was isolated from the frozen tissues using Takara RNAiso Plus (Takara Bio. Inc., Otsu, Shiga, Japan) according to the manufacturer's protocol. Genomic DNA (gDNA) was removed and cDNA was reverse-transcribed by using Takara PrimeScript TM RT reagent Kit with gDNA Eraser (Takara Bio. Inc., Otsu, Shiga, Japan) in a T100 TM Thermal Cycler System (BioRad, USA). The experimental protocol was first gDNA removal (42 °C 2 min), followed by reverse transcription (37 °C 15 min, 85 °C 5 s). Subsequently, all samples were amplified by a 25 μl reaction volume in a CFX96 TM Real-time PCR Detection System (BioRad, USA), using SYBR ® Premix Ex Taq TM Ⅱ (Takara Bio. Inc., Otsu, Shiga, Japan). All samples were run in triplicate. TOP2A, NDC80, CEP55, CDKN3, CDK1 were investigated. The amplification program was repeated for 40 cycles. Primer sequences are shown in Table 2 . For relative quantification, gene expression was normalized to expression of GAPDH housekeeping gene and compared by 2 −ΔΔCT method. Table 2 . Primer sequences used to amplify target genes by real-time RT-PCR.
Target Gene Primer Sequence
TOP2A Forward 5'-GCGGGCTAAAGGAAGGTTCA-3' Reverse 5'-TGACACTTCCATGGTGACGG-3' NDC80 Forward 5'-ATCAAGGACCCGAGACCACT-3' Reverse 5'-ATGTATGAGGAGCCCCCACT-3' CEP55 Forward 5'-GGAGGGCAGACCATTTCAGAG-3' Reverse 5'-AGGCTTCGATCCCCACTTAC-3' CDKN3 Forward 5'-CAGCCTGCGAGACCTAAGAG-3' Reverse 5'-TGTGCAGCTAATTTGTCCCG-3' CDK1 Forward 5'-TTCTTTCGCGCTCTAGCCAC-3' Reverse 5'-TCGGGTAGCCCGTAGACTTT-3' GAPDH Forward 5'-AGAAGGCTGGGGCTCATTTG-3' Reverse 5'-AGGGGCCATCCACAGTCTTC-3'
Western-Blotting analysis
Proteins were extracted from frozen samples using the Radio Immunoprecipitation Assay Lysis Buffer (Shanghai Beyotime Bio. Co., Shanghai, China). One hundred μg of each sample was electrophoresed on a 10% sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel (Wuhan Boster Biological Technology Ltd., Wuhan, China) and transferred to polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, USA) using a BioRad wet transfer system. The membrane was blocked for 2 h at room temperature with Tris-buffered saline with 0.1% Tween (TBST) containing 5% non-fat dry milk solution. The membrane was incubated overnight with primary TOP2A antibody (Rabbit Polyclonal to TOP2A, A0726, ABclonal) at dilution of 1:1000. After washing several times with PBS, the membranes were incubated with anti-rabbit immunoglobulin G (IgG) linked with horseradish peroxidase at a 1:10,000 dilution (Thermo Scientific Fisher; Rockford, IL, USA) for 1 hour at room temperature. Detection of reaction antigen was performed with an enhanced chemiluminescence (ECL) kit (Thermo Scientific Fisher). A monoclonal mouse antibody against GAPDH (1:5000; Sigma-Aldrich) was used as a control to ascertain equivalent loading. All samples were independently repeated for 3 times.
Immunofluorescence
Tissues were sectioned in 10 μm thick slices and thaw, mounted onto glass slides using a cryostat (Leica CM 1850, Wetzlar, Germany), air-dried, and fixed for 10 min in ice cold acetone. Slides were washed in PBS and incubated for 2 h in a mixture of PBS supplemented with 0.2% Triton X-100 and 0.1% bovine serum albumin, followed by incubation overnight with the primary antibody (1:100). The secondary antibody employed to visualize the localization of TOP2A is Cy3-conjugated goat anti-rabbit IgG (1:1000). DAPI was used for staining the nucleus. Visualization was done with a laser microscope (Olympus, Tokyo, Japan).
Results
DEGs between ACC and healthy control samples
A flowchart of current study schedule was displayed in Figure 1 . A sum of 6 GEO datasets were examined and analyzed for further investigation (Table 1 ). After quality assessment and data preprocessing, the expression matrices were obtained from every GEO dataset. By using a rank aggregation analysis of these six expression matrices, we identified 87 statistically significant genes including 26 up-regulated and 61 down-regulated genes in ACC samples compared with normal adrenal gland tissues. The top 20 down-regulated genes and top 20 up-regulated genes were showed in Figure 2 .
Functional and pathway enrichment analysis of the 87 DEGs
To get deeper understanding of the DEGs function, all DGEs were sent to the KEGG Orthology Based Annotation System (http://kobas.cbi.pku.edu. cn/index.php). The results from GO analysis indicated 20 biological processes enriched (p value < 0.05). Among those, we found that extracellular region, extracellular space, regulation of cell growth, response to hypoxia, response to mechanical stimulus and extracellular matrix were the most significant biological processes (p value < 0.001) ( Figure 3A) . Furthermore, 14 significant KEGG pathways (p value < 0.05) were enriched out of 87 DEGs, including tyrosine metabolism, complement and coagulation cascades, cell cycle, gap junction, metabolic pathways and steroid hormone biosynthesis ( Figure 3B ). 
PPI network of 87 DEGs
As to the PPI network, under the cutoff of confidence > 0.4 and degree of connectivity >20, five genes (TOP2A, CDK1, NDC80, CDKN3 and CEP55) were regarded as hub genes among 87 DGEs. Then, these five hub genes were chosen for further analysis (Figure 4 ).
Assessment of five hub genes in TCGA and Oncomine database
To assess the roles of these five hub genes in ACC, gene expression validations were performed, and all of five hub genes were also upregulated in the TCGA and Oncomine data ( Figure 5, 6 ). 
Association of five hub genes expression with the prognosis of ACC
The survival curves were drawn to evaluate the association between five hub genes expression levels and the prognosis of ACC, respectively. ACC prognosis including OS and DFS analysis were conducted. We identified shorter OS duration ( Figure  7A ) and DSF duration ( Figure 7B ) in cases of higher expression levels of TOP2A, CDK1, NDC80, CDKN3 and CEP55.
Association of five hub genes expression with the four pathology stages and pathology T stages of ACC
Kruskal-Wallis test was operated to confirm the five hub genes in TCGA database, positive relationship was found between all of five hub genes and ACC progression (pathology stage and pathology T stage, FDR < 0.01) (Figure 8 ). The mRNA expression of five hub genes in ACC and normal tissues.
Expression of TOP2A, NDC80, CEP55, CDKN3
and CDK1 mRNA were determined using quantitative real time RT-PCR between ACC samples and normal ones ( Figure 9A ). The most upregulated gene TOP2A protein was further quantified with Western-blotting analysis ( Figure 9B ). TOP2A protein bands was detected at a molecular weight of 200 kDa. A significant 2.3-fold increase of TOP2A at translational level was observed between ACC tissues and normal adrenal gland tissues (p = 0.0116).
Immunofluorescence of TOP2A in ACC and normal tissues
As shown in Figure 9C , TOP2A is localized in adrenal cortical cytoplasm and nucleus. In ACC, TOP2A was mainly present in adrenocortical cells nuclei and partly present in the adrenocortical cytoplasm. In normal adrenal gland, the localization is similarly with that in ACC, but in normal adrenal gland, the fluorescence intensity is significantly weaker than that of ACC. That is to say, immunofluorescence also confirms that the expression of TOP2A in ACC is higher than that in normal tissues.
Discussion
The gene expression profiles of neoplasms can be examined comprehensively through microarray technology. It is quickly being used to solve various oncology and pathology issues, such as neoplasms classification [26] [27] [28] [29] [30] [31] . It can also serve for the purpose of gene detection [32, 33] to integrate other analogous technologies [34, 35] .
The biology knowledge of cancer has been greatly advanced through modern molecular analysis. This method has also emphasized the practical value of these transcriptomic, epigenomic, and genomic biomarkers as candidate indicator to predict and diagnose disease. The comprehensive gene expression profiles methods based on RNA in malignant diseases has been considerably developed [36] [37] [38] . Specific gene expression profiles have been identified by many landmark series to distinguish ACCs from the benign adrenal disease [14, 15, 39] . These lay the foundation for the attempt to link these profiles with clinical applications. [24, 39, 40] .
In present study, six gene expression matrices of different GEO data sets with a total of 165 ACC samples and 36 normal adrenal gland samples were analyzed and after robust rank analysis, 87 significant genes were chosen for further PPI network. Five hub genes (TOP2A, NDC80, CEP55, CDKN3 and CDK1) with confidence score > 0.4 and degree of connectivity > 20 were then selected for further validation in TCGA, GTEx and Oncomine database. These five hub genes had a very significant statistical distinction with poor prognosis (OS and DFS) and the progression (pathology T stages and pathology stages).
Topoisomerase II Alpha (TOP 2A) encoded a DNA topoisomerase, an enzyme that controlled and altered the topologic states of DNA during transcription. Study had demonstrated that TOP2A identified and provided epigenetic basis for the inventive integration of medical treatment for malignant prostate cancer [41] . Moreover, it is possible for use to reveal the predictive power of TOP2A in nasopharyngeal carcinoma and breast cancer [42, 43] . It was reported to be a promising biomarker in progression and prognosis of several kinds of tumor [44] [45] [46] [47] . Importantly, Meenu Jain et al demonstrated that the expression of TOP2A is out of control in ACC. TOP2A is responsible for the proliferation and the invasive behavior in ACC cells. It is a desirable goal for ACC treatment. Among the examined TOP2A inhibitors, aclarubicin is a fine potential agent to be assessed in clinical trials for locally aggravated and metastatic ACC in the future [48] .
As one of the key elements of outer kinetochore, nuclear division cycle 80 (NDC80) is crucial for the steady development of kinetochore-microtubule anchoring and accurate chromosome separation during mitosis. NDC80 had not reported differentially expressed in ACC compared with normal ones. But several studies found that the mRNA levels of NDC80 which shows strong upregulation escalate significantly in the benign breast tumors in comparison with the healthy breast tissues [49] . What's more, NDC80 was also found upregulated in hepatocellular carcinoma [50] . Centrosomal protein 55 (CEP55), with many aliases such as FLJ10540, C10orf3 and URCC6, is highly expressed many kinds of cancers including human gastric cancer, nasopharyngeal carcinoma, colorectal, cancer and prostate cancer [51] [52] [53] [54] . In oral cavity squamous cell carcinoma, CEP55 upregulation is a common abnormality and is linked with tumor development and abbreviated survival. Moreover, the overly expressed CEP55 in malignant oral cancer cells cause the expression of FOXM1 and out of control of MMP-2 which lead to the migration and infiltration of the oral cancer cells [55] . In addition, there may be association between CEP55 and PI3K. CEP55 adjusts the activity of PI3K and lead to cell mutation in hepatocellular carcinoma. The cancer cells may be reverted to their normal condition by the inhibition of CEP55 expression or its other related forms [56] .
Cyclin-dependent kinase inhibitor 3 (CDKN3) participate the control of cell cycle. It functions include the regulation of the mitosis through CDK1 signaling pathway [57] , the prevention of G1/S transformation by connecting to CDK2 kinase and prohibition of Rb phosphorylation [58, 59] . It also forms compound with p53 and Mdm2 protein, reduces p21 and promotes cell cycle process [60] . Elevation of CDKN3 was also detected in cancers like breast, prostate and renal cancers [61, 62] . What's more, overexpression of CDKN3 linked with high death rate in cervical cancer [63] , and highly unrecognizable hepatocellular carcinoma (HCC) [59, 62] .
Cyclin dependent kinase 1 (CDK1), or CDC2, belongs to serine/ threonine protein kinase family. It is a catalytical subunit factor that boosts M-phase. As a highly conserved protein kinase complex, it is vital for G1/S and G2/M phase transitions in the process of eukaryotes cell cycle. Glover et al described the upregulation of CDK1 in ACC samples [64] . Based on the meta-analysis of gene expression and extensive genetic assortment ACC profile data, this kinase was also found to be maladjusted in cell cycle pathways [65] .
Conclusions
Current study identified five hub genes (TOP2A, NDC80, CEP55, CDKN3 and CDK1) through robust rank analysis and PPI networks. Even with some limitations, such as, the genomic results were based purely on microarray data which does not always reflect gene expression and the sample size used to verify the gene expression is not large enough, our results were in general validated in this large and geographical distinct cohort (from TCGA database). This validation proves the clinical relevance of the identified signatures for ACC patients. Our data further demonstrated the association of these hub genes with the development and limited prediction of ACC. To our knowledge, these genes (NDC80, CEP55 and CDKN3) were first reported to be overexpressed in ACC and were correlated with the development and prediction of ACC. However, further studies are needed before a translation to clinical practice, namely regarding sample collection in this hard to reach population. In general, it was found these five hub genes might play important roles in ACC progress and prognosis. 
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